Provided by Tiger Fintech (Singapore) Pte. Ltd.

DaVita HealthCare Partners

140.00
-1.6100-1.14%
Post-market: 140.000.00000.00%19:54 EST
Volume:1.07M
Turnover:150.15M
Market Cap:11.20B
PE:13.05
High:142.80
Open:141.38
Low:139.44
Close:141.61
Loading ...

DaVita: A Buffett-Backed Healthcare Stock Worth Watching

GuruFocus.com
·
5 hours ago

DaVita Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Mar

With EPS Growth And More, DaVita (NYSE:DVA) Makes An Interesting Case

Simply Wall St.
·
04 Mar

Rap star Pusha T's 'favorite business' venture is surprisingly a US medical-based service company

Moneywise
·
01 Mar

Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

Zacks
·
28 Feb

DaVita, YMCA of the USA deepen collaboration for kidney health

TIPRANKS
·
27 Feb

Ymca of the USA Deepens Collaboration With DaVita to Drive Kidney Health Initiatives in Seven Communities

THOMSON REUTERS
·
27 Feb

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

GlobeNewswire
·
27 Feb

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
27 Feb

Berkshire Hathaway sells 750,000 DaVita shares

Reuters
·
20 Feb

Berkshire Hathaway Sells 750,000 Shares of DaVita Between February 14 and February 19, NOW Owns About 35.14 Million Shares, SEC Filing Shows

THOMSON REUTERS
·
20 Feb

DaVita Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
19 Feb

TD Cowen Adjusts Price Target on DaVita to $165 From $150, Keeps Hold Rating

MT Newswires Live
·
18 Feb

DaVita Is Maintained at Equal-Weight by Barclays

Dow Jones
·
18 Feb

DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health

ACCESS Newswire
·
17 Feb

Analysts Offer Insights on Healthcare Companies: DaVita (DVA) and Charles River Labs (CRL)

TIPRANKS
·
17 Feb